We further identify NRF2 as the first direct target of SAL, and elucidate a precise mechanism of action by which, SAL targets NRF2/SIRT3 pathway and attenuates Aβ pathology, restores neurite morphology, and improves cognitive function in AD mice. The gene discussed is SIRT3; the disease is Alzheimer disease.